Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2019; 44(4): 713-716


Is Antimullerian hormone a true ovarian marker for fibroid, Polycystic Ovary Syndrome and hypogonadotropic hypogonadism in infertile women?

Benish Farooq,Sarwat jahan,Jehan Ara,Usman Ghani,Misbah Haneef,Ahsan Malik,Saleem Abbasi.




Abstract

Objective: To measure Anti mullerian Hormone (AMH) concentration as a true ovarian marker in polycystic ovary syndrome (PCOS), fibroids and hypogonadotropic hypogonadism (HH).
Methodology: This study was a prospective comparative trial conducted from January to November 2014 at Department of Animal science, Quaid –e –Azam University in collaboration with Salma & Kafeel Medical Center, Islamabad, Pakistan. A total of 128 females were enrolled in the study.
Results: Significant increase (P

Key words: Infertility, AMH, PCOS, hypogonadotropic Hypogonadism, fibroids.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Refer & Earn
JournalList
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.